Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity
NCT ID: NCT06441409
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2024-04-15
2025-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After lifestyle intervention, which part of the body shows the fastest fat mobilization? Which part shows the slowest fat mobilization? Which area's fat mobilization is most related to the alleviation of glucose metabolism? Is there a relationship between the fat deposition in organs and the iron deposition in organs?
Researchers will compare the liver fat, pancreatic fat, visceral fat, subscutaneous fat, liver and pancrease iron depositon after lifestyle intervention using self pre-and post-control .
Participants will:
Receive the lifestyle intervention in outpatient. Visit the clinic once after 6 months for checkups and tests. Keep a diary of their diet.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Health Lifestyle on Body Weight
NCT05608226
Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults
NCT03972631
Intermittent Fasting in Nonalcoholic Fatty Liver Disease
NCT04355910
Clinical Study on the Treatment of MAFLD With Ganzhixiao Capsules
NCT06848907
The Effect of Calorie Deprivation on Adipose Tissue Distribution
NCT01658397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lifestyle intervention
Patients were intervened with lifestyle only and returned to clinic for tests in 6 months.
Lifestyle intervention included the diet and exercise. Diet was an energy-restricted balanced diet. Exercise requires 5 days a week and 30 minutes every day.
Lifestyle intervention
Patients were intervened with lifestyle only and returned to clinic for tests in 6 months.
Lifestyle intervention included the diet and exercise. Diet was an energy-restricted balanced diet. Exercise requires 5 days a week and 30 minutes every day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle intervention
Patients were intervened with lifestyle only and returned to clinic for tests in 6 months.
Lifestyle intervention included the diet and exercise. Diet was an energy-restricted balanced diet. Exercise requires 5 days a week and 30 minutes every day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have a BMI greater than 28.0 kg/m2
* exhibit abdominal obesity, defined as a waist circumference of at least 90 cm for men and 85 cm for women
* willing to undergo a 6-month lifestyle intervention
Exclusion Criteria
* a prior history of pancreatic diseases;
* combination of drug-induced hepatitis, autoimmune hepatitis, and viral hepatitis;
* with a definitive diagnosis of diabetes who have already started medication treatment;
* severe complications from type 2 diabetes or other significant diseases;
* usage of drugs affecting body weight, insulin sensitivity, or metabolic-associated fatty liver disease in the past three months (such as insulin, glucocorticoids, thiazolidinediones, metformin, SGLT-2 inhibitors, or GLP-1 receptor agonists);
* with malignant tumors;
* acute or chronic infection;
* with elevated transaminase levels of unknown cause;
* hemochromatosis;
* with iron deficiency anemia who are receiving iron supplementation;
* who have donated blood or received a transfusion within the past six months;
* who have experienced cardiovascular events within the past six months;
* with acute or chronic blood loss;
* alcohol dependence, defined as ethanol intake exceeding 140 g/week for men and 70 g/week for women;
* pregnant and lactating women.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Third Xiangya Hospital of Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ping Jin
Role: STUDY_CHAIR
The Third Xiangya Hospital of Central South University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No. 2022JJ40749
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
22218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.